
Journal of Medicinal Chemistry p. 366 - 378 (1995)
Update date:2022-08-03
Topics:
Bridger
Skerlj
Thornton
Padmanabhan
Martellucci
Henson
Abrams
Yamamoto
De Vreese
Pauwels
De Clercq
We have previously described the potent and selective inhibition of several strains of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) by JM2763, an n-propyl-linked dimer of the 1,4,8,11- tetraazamacrocyclic(cyclam) ring system. Upon further investigation, we have also found that incorporating an aromatic rather than aliphatic linker leads to analogs with higher antiviral potency. The prototype, JM3100 (19a, isolated as the octahydrochloride salt), which contains a p- phenylenebis(methylene) moiety linking the cyclam rings, inhibited the replication of HIV-1 (III(B)) and HIV-2 (ROD) at EC50's of 4.2 and 5.9 nM, respectively, while remaining nontoxic to MT-4 cells at concentrations exceeding 421 μM. In order to identify the structural features of bis- tetraazamacrocycles required for potent activity, we have prepared a novel series of phenylenebis(methylene)-linked analogs, in which the macrocyclic ring size was varied from 12 to 16 ring members. Depending upon the substitution of the phenylenebis-(methylene) linker (para or meta), sub- micromolar anti-HIV activity was exhibited by analogs bearing macrocycles of 12-14 ring members but with varying cytotoxicity to MT-4 cells. Furthermore, while we found that identical macrocyclic rings are not required for activity, substituting an acyclic polyamine equivalent for one of the cyclam rings in 19a resulted in a substantial reduction in anti-HIV potency, clearly establishing the importance of the constrained macrocyclic structure. A short series of transition metal complexes of 19a were also prepared and evaluated. Complexes of low kinetic stability such as the bis-zinc complex retained activity comparable to that of the parent compound. Finally, the activity of bicyclam analogs appears to be insensitive to the electron-withdrawing or - donating properties of substituents introduced onto the linker, but sterically hindering groups such as phenyl markedly reduced activity. As a result, several analogs with anti-HIV potency comparable to that of 19a have been identified.
View MoreContact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Shenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
Zhongshan Haihong Medicine Co., Ltd.
Contact:86-0760-86925778 (0)18824993998
Address:A7 building,lianyuan road Torch Hi-tech Industrial Development Zone
Hangzhou TJM Chemical Trade Co., Ltd
Contact:86-571-88223276 86-13388481653
Address:2221#,Boyuexuan,1860# Binsheng Road,Binjiang District, Hangzhou CityZhejiang Province, 310051, P. R. China
Zhengzhou Xinlian Chemical Tech Co. ,Ltd
Contact:0371-65771781 021-52042910
Address:H Part, Building I, No. 700 Gonglu Road, Pudong New Area, Shanghai
Doi:10.1016/0040-4020(81)85025-9
(1981)Doi:10.1016/j.tetlet.2013.08.032
(2013)Doi:10.1007/BF00472164
()Doi:10.1016/S0040-4039(01)93328-3
(1989)Doi:10.1021/j150197a004
(1919)Doi:10.1016/S0040-4039(00)94711-7
(1990)